Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Pegcetacoplan |
| Trade Name | |
| Synonyms | APL2|APL-2|APL 2 |
| Drug Descriptions |
Pegcetacoplan binds to and inhibits C3 and C3b, resulting in decreased activation of the complement pathway and potentially leading to reduced inflammation and cell lysis (PMID: 33464651, NCI Drug Dictionary) |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C170296 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bevacizumab + Pegcetacoplan + Pembrolizumab | Bevacizumab Pegcetacoplan Pembrolizumab | 0 | 1 |
| Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + Pegcetacoplan | Fluorouracil Irinotecan Leucovorin Oxaliplatin Pegcetacoplan | 0 | 1 |
| Pegcetacoplan | Pegcetacoplan | 0 | 0 |
| Pegcetacoplan + Pembrolizumab | Pegcetacoplan Pembrolizumab | 0 | 1 |